Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Pedestrian Killed in Crash on State Route 273 Near Alexander Avenue


Victim Hit by Car in Fatal Anderson Accident

Anderson, CA (March 23, 2020) – A pedestrian was killed in a crash in Anderson. The fatal accident occurred on the morning of March 23 on State Route 273.

A pedestrian was hit by a car on State Route 273, near Alexander Avenue. Emergency crews found the victim in the roadway. The person later died. The driver of the vehicle was not injured.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Anderson

#96007


November 13, 2019

1 Injured in Crash on Interstate 15 Near Centre City Parkway

Border Patrol Vehicle Involved in Escondido Accident...


May 25, 2020

Aide Bustamante, 1 Other Person Killed in Crash on 5 Freeway Near Paramount Boulevard

Cash Rencanzone Arrested for Hit and Run in Fatal Downey Accident...


January 22, 2020

Man Killed in Fiery Crash on Interstate 280 Near Trousdale Drive

Pickup Truck Hits Tree, Pole in Fatal Burlingame Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.